These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 10639606

  • 1. Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy.
    Ponsford S, Willison H, Veitch J, Morris R, Thomas PK.
    Muscle Nerve; 2000 Feb; 23(2):164-74. PubMed ID: 10639606
    [Abstract] [Full Text] [Related]

  • 2. Neuropathy associated with monoclonal gammopathies of undetermined significance.
    Gosselin S, Kyle RA, Dyck PJ.
    Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
    [Abstract] [Full Text] [Related]

  • 3. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Siciliano G, Moriconi L, Gianni G, Richieri E, Vignocchi MG, Rossi B.
    Acta Neurol Scand; 1994 Feb; 89(2):117-22. PubMed ID: 8191874
    [Abstract] [Full Text] [Related]

  • 4. The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings.
    Yeung KB, Thomas PK, King RH, Waddy H, Will RG, Hughes RA, Gregson NA, Leibowitz S.
    J Neurol; 1991 Oct; 238(7):383-91. PubMed ID: 1660064
    [Abstract] [Full Text] [Related]

  • 5. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy.
    Simovic D, Gorson KC, Ropper AH.
    Acta Neurol Scand; 1998 Mar; 97(3):194-200. PubMed ID: 9531437
    [Abstract] [Full Text] [Related]

  • 6. IgM MGUS anti myelin-associated glycoprotein neuropathy can rarely express as a predominantly distal motor neuropathy.
    Galassi G, Tondelli M.
    Muscle Nerve; 2016 May; 53(5):827-8. PubMed ID: 26690862
    [No Abstract] [Full Text] [Related]

  • 7. Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases.
    Ellie E, Vital A, Steck A, Boiron JM, Vital C, Julien J.
    J Neurol; 1996 Jan; 243(1):34-43. PubMed ID: 8869385
    [Abstract] [Full Text] [Related]

  • 8. Revisiting the spectrum of IgM-related neuropathies in a large cohort of IgM monoclonal gammopathy.
    Bardel B, Molinier-Frenkel V, Le Bras F, Ayache SS, Nordine T, Lefaucheur JP, Planté-Bordeneuve V.
    J Neurol; 2022 Sep; 269(9):4955-4960. PubMed ID: 35505107
    [Abstract] [Full Text] [Related]

  • 9. [Neurological manifestations of monoclonal gammopathies].
    Chassande B, Léger JM.
    Rev Prat; 1993 Feb 01; 43(3):314-6. PubMed ID: 8389055
    [Abstract] [Full Text] [Related]

  • 10. Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS.
    Suarez GA, Kelly JJ.
    Neurology; 1993 Jul 01; 43(7):1304-8. PubMed ID: 8327128
    [Abstract] [Full Text] [Related]

  • 11. IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy.
    Mehndiratta MM, Sen K, Tatke M, Bajaj BK.
    J Neurol Sci; 2004 Jun 15; 221(1-2):99-104. PubMed ID: 15178222
    [Abstract] [Full Text] [Related]

  • 12. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N, Schwärzler A, Göbel G, Löscher W, Wanschitz J, Gunsilius E.
    Oncotarget; 2017 Jan 17; 8(3):5081-5091. PubMed ID: 27974705
    [Abstract] [Full Text] [Related]

  • 13. Immunostaining of skin biopsy adds no diagnostic value in MGUS-associated peripheral neuropathy.
    Al-Zuhairy A, Schrøder HD, Plesner T, Abildgaard N, Sindrup SH.
    J Neurol Sci; 2015 Feb 15; 349(1-2):60-4. PubMed ID: 25582978
    [Abstract] [Full Text] [Related]

  • 14. [Neuropathy associated with dysglobulinemia and monoclonal gammopathy].
    Saito T.
    Nihon Rinsho; 1994 Nov 15; 52(11):2976-83. PubMed ID: 7996697
    [Abstract] [Full Text] [Related]

  • 15. Peripheral neuropathy with gammopathy responding to plasmapheresis.
    Frayne J, Stark RJ.
    Clin Exp Neurol; 1985 Nov 15; 21():195-200. PubMed ID: 3032483
    [Abstract] [Full Text] [Related]

  • 16. Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities.
    Notermans NC, Wokke JH, Lokhorst HM, Franssen H, van der Graaf Y, Jennekens FG.
    Brain; 1994 Dec 15; 117 ( Pt 6)():1385-93. PubMed ID: 7820574
    [Abstract] [Full Text] [Related]

  • 17. Prognosis of polyneuropathy due to IgM monoclonal gammopathy: a prospective cohort study.
    Niermeijer JM, Fischer K, Eurelings M, Franssen H, Wokke JH, Notermans NC.
    Neurology; 2010 Feb 02; 74(5):406-12. PubMed ID: 20124206
    [Abstract] [Full Text] [Related]

  • 18. Neuropathies associated with IgG and IgA monoclonal gammopathy.
    Nobile-Orazio E, Casellato C, Di Troia A.
    Rev Neurol (Paris); 2002 Oct 02; 158(10 Pt 1):979-87. PubMed ID: 12407307
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal gammopathy and neuropathy.
    Notermans NC.
    Curr Opin Neurol; 1996 Oct 02; 9(5):334-7. PubMed ID: 8894407
    [Abstract] [Full Text] [Related]

  • 20. Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
    Dyck PJ, Low PA, Windebank AJ, Jaradeh SS, Gosselin S, Bourque P, Smith BE, Kratz KM, Karnes JL, Evans BA.
    N Engl J Med; 1991 Nov 21; 325(21):1482-6. PubMed ID: 1658648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.